ZJQ-18041-11221
3 vaccinations
7 coded responses
22 check-ins
7 free-text entries
7 call cases
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 606 / IL
- Registered
- 2020-12-24
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-17
Dose 1 — Pfizer-BioNTech
-
2020-12-24
Registered in v-safe
-
2020-12-24
Survey response — day 7, dose 1MedDRA: Blood pressure increased — Feeling: Good · Site: Pain · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: My blood pressure was elevated for 3 days after the injection. It has returned to normal by day 4MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2020-12-24
Report sent to call center — day 7, dose 1Be unable to do your normal daily activities1 call case(s)
- 2020-12-31
-
2021-01-07
Dose 2 — Pfizer-BioNTech
-
2021-01-09
Survey response — days 1–6 daily, dose 2MedDRA: Injection site pain — Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea · Be unable to do your normal daily activitiesFree text: painful arm at injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-09
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
-
2021-01-10
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-10
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
-
2021-01-11
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-01-12
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-01-13
Survey response — days 1–6 daily, dose 2MedDRA: Office visit — Feeling: Poor · Fever · Chills, Headache, Nausea · Get care from a doctor or other healthcare professionalFree text: Visit in person with my internistMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-13
Report sent to call center — days 1–6 daily, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-01-15
Health check-in — day 7, dose 2Feeling: Fair · Fever · Chills, Headache, Fatigue or tiredness, Nausea · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationAdult check-in
-
2021-01-15
Report sent to call center — day 7, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-01-21
- 2021-01-28
- 2021-02-04
- 2021-02-12
- 2021-02-18
- 2021-03-13
- 2021-04-08
-
2021-09-14
Dose 3 — Pfizer-BioNTechCo-administered: Flu
-
2021-09-29
Survey response — day 14, dose 3MedDRA: Arthralgia, Exercise tolerance decreased, Fatigue, Loss of personal independence in daily activities, Mobility decreased, Myalgia — Feeling: Good · Be unable to do your normal daily activitiesFree text: Fatigue. I am occasionally unable to exercise or do my ADL's as before. Intermittent joint and muscle pain making it difficult to take stairs and perform at my prior high level of fitness ( martial arts).MedDRA releases: 2024-11 · check-in free text available
- 2021-10-05
-
2021-10-12
Survey response — day 28, dose 3MedDRA: Fatigue, Headache — Feeling: FairFree text: Headaches daily and unusual fatigueMedDRA releases: 2024-11 · check-in free text available
- 2021-10-19
- 2021-10-26
- 2021-12-14
-
2022-03-15
Survey response — 6 months, dose 3MedDRA: Office visit, Pericarditis — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: Symptoms: Pericarditis · Healthcare visit (other): Cardiologist visits and testsMedDRA releases: 2024-11 · check-in free text available
-
2022-03-15
Report sent to call center — 6 months, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
- 2022-03-16
-
2022-03-23
Call successfulParticipant prefers to complete VAERS report online
-
2022-09-16
Survey response — 12 months, dose 3MedDRA: COVID-19, Keratitis, Office visit — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Symptoms: Covid kerititis bilateral · Healthcare visit (other): Daily office exams of eyes for 10 daysMedDRA releases: 2024-11 · check-in free text available
-
2022-09-16
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-09-19
Call successfulParticipant prefers to complete VAERS report online
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-17 | Pfizer-BioNTech | |
| 2 | 2021-01-07 | Pfizer-BioNTech | |
| 3 | 2021-09-14 | Pfizer-BioNTech | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2020-12-24 | Successful | Participant prefers to complete VAERS report online |
| 2021-01-09 | Successful | Participant prefers to complete VAERS report online |
| 2021-01-10 | Successful | Participant prefers to complete VAERS report online |
| 2021-01-13 | Successful | Participant prefers to complete VAERS report online |
| 2021-01-15 | Successful | Participant prefers to complete VAERS report online |
| 2022-03-15 | Successful 2022-03-23 |
Participant prefers to complete VAERS report online |
| 2022-09-16 | Successful 2022-09-19 |
Participant prefers to complete VAERS report online |
Free text
Release 1 — day 7, dose 1
Systemic reaction (other): My blood pressure was elevated for 3 days after the injection. It has returned to normal by day 4
Release 1 — days 1–6 daily, dose 2
Systemic reaction (other): painful arm at injection site
Healthcare visit (other): Visit in person with my internist
Release 9 — day 14, dose 3
Symptoms: Fatigue. I am occasionally unable to exercise or do my ADL's as before. Intermittent joint and muscle pain making it difficult to take stairs and perform at my prior high level of fitness ( martial arts).
Release 10 — day 28, dose 3
Symptoms: Headaches daily and unusual fatigue
Release 11 — 6 months, dose 3
Release 12 — 12 months, dose 3
Symptoms: Covid kerititis bilateral
Healthcare visit (other): Daily office exams of eyes for 10 days
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | ✓ | ✓ | ✓ |
| SD | Arthralgia | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Exercise tolerance decreased | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Keratitis | · | · | ✓ |
| SD | Loss of personal independence in daily activities | · | · | ✓ |
| SD | Mobility decreased | · | · | ✓ |
| SD | Myalgia | · | · | ✓ |
| SD | Pericarditis | · | · | ✓ |
| SRO | Blood pressure increased | ✓ | ✓ | ✓ |
| SRO | Injection site pain | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release